Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (326)
ARTG (261)
Prescription medicine registration (29)
Prescription medicine evaluation (3)
Designation or determination (2)

Date

2026 (47)
2025 (31)
2024 (51)
2023 (161)
2022 (30)
2021 (31)
2020 (45)
2019 (26)
2018 (50)
2017 (35)
2016 (77)
2015 (2)
2014 (1)
2013 (5)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

621 result(s) found, displaying 121 to 130

ALENDRONATE PLUS D3 - DRLA 70 mg/140 microgram alendronate (as sodium) and colecalciferol 140 microgram (5600 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ALENDRONATE PLUS D3 - DRLA 70 mg/70 microgram alendronate (as sodium) and colecalciferol 70 microgram (2800 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TELMIZ telmisartan 40mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TELMISARTAN-DRLA telmisartan 80mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TELMISARTAN-DRLA telmisartan 40mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TELMICOR telmisartan 80mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TELMICOR telmisartan 40mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TELMIZ telmisartan 80mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
TICAGRELOR DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

15 May 2024

Prescription medicine registration

Active ingredients: ticagrelor.
RIVAROXABAN DR.REDDY'S rivaroxaban 20 mg tablet blister pack (290217)

4 January 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN DR.REDDY'S rivaroxaban 20 mg tablet blister pack.

Pages

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Page 16
Page 17
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.